3 news items
MAIA Biotechnology Inc (MAIA) Stock Surges as Company Prepares to Present Promising Data at BIO International Convention
CRL
IQV
MAIA
31 May 24
is for informational purposes only and does not constitute financial advice or an endorsement of MAIA or its strategies. FOR EDUCATIONAL AND INFORMATION PURPOSES
BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
TECH
7 May 24
case studies. The topics covered will include characterizing biodistribution and safety of cell and gene therapies, protein analytics strategies
Navigating 4 Analyst Ratings For Bio-Techne
TECH
18 Apr 24
debt-to-equity ratio of 0.28, Bio-Techne adopts a prudent financial strategy, indicating a balanced approach to debt management
- Prev
- 1
- Next